RE: Everything looking good30 Jun 2023 08:19
Seriously cannot see Avacta being in existence in a year's time. It would make no sense that,if the data from P1a/b is as good as it's been to date, a major would allow a competitor to snaffle it.
Company's have been taken over on the basis of single drugs, let alone a platform that can be adapted to many drugs.
Those stating 7years are in cloud cuckoo land, i think 2 is a stretch and that's not ramping.